Medtech / The UAE: Early Adopters of Cutting-Edge Solutions
In some respects, is it perhaps the medtech sector that has most to be excited about in the UAE’s domestic…
MIDDLE EAST & AFRICA
Top 10 Pharma Companies in Morocco Ranking
The top 10 pharma companies in Morocco ranked by sales value for Q4 2018. French giant Sanofi takes top spot,…
Hot Topics / Moroccan Pharma
In 2020, PharmaBoardroom has met with stakeholders from across the Moroccan healthcare and life sciences…
Morocco Local Production Snapshot
A new IQVIA study sponsored by LEMM, the Moroccan association of multinationals looked at 3,437 references sold on…
Manufacturing / Morocco: Becoming a Pharma Production Hub for Africa
Multinational pharmaceutical companies are increasingly seeing Morocco as a top manufacturing destination for the…
MENA / Moroccan Pharma Companies to Know
Morocco, one of the most significant pharmaceutical markets in Africa, boasts a number of domestic firms. Here we…
MEA / Gulf Healthcare Costs to Rise Drastically in 2020
Growing incidence of lifestyle-related diseases, coupled with high drug prices, are driving up healthcare costs at…
Local Manufacturing / New IQVIA Study Sparks Controversy in Moroccan Pharma
Ensuring the country’s “sanitary sovereignty” has long been a key policy for Morocco and its government. In…
Company Spotlight / Fujifilm MEA: From Film to the Future
When the photographic film industry faced a crisis in the early 2000s, market leader Kodak began to struggle and…
In Conversation
Salim Ennaji – Delegate Director General, Laprophan, Morocco
Salim Ennaji, delegate director general of Moroccan local champion Laprophan discusses how he has refreshed the company’s outlook in his three years at the helm and outlines how Moroccan generics firms will have to adapt to survive in a challenging market environment. We have managed to build very close relationships with our partners. The “youngest” partnership we have is…
Latest Reports
Focus on Egypt
Striking the Access/Innovation Balance in Egyptian…
As Egypt rolls out Universal Health Insurance with the aim of achieving full…
GE Healthcare Egypt: Reimagining Care Provision
Amro Kandil, managing director Northeast Africa for GE Healthcare, outlines how…
Read more from Egypt >>
Focus on UAE
The UAE: A Gathering Force
Accounting for less than two percent of the global pharmaceutical market, the…
Medtronic: Taking Tech to Emerging Markets
Global medtech giant Medtronic manages a highly diverse region that spans both…
Read more from UAE >>
Focus on Morocco
Morocco: Standing Firm
Valued by Fitch at a trifling USD 1.6 billion, the Moroccan pharma sector can be…
Oncology in Morocco: Access Challenges & New Solutions
Morocco has made admirable progress in building a national oncology network in…
Read more from Morocco >>
Focus on Turkey
Acıbadem’s Grand Ambitions
There is perhaps no Turkish company in the healthcare sector that is more…
Pharma Faces: Ferhat Farsi, CinnaGen İlaç
Dr Ferhat Farsi, CEO and founding partner of CinnaGen İlaç, shares his…
Read more from Turkey >>
The Long Read / Morocco: Standing Firm
Valued by Fitch at a trifling USD 1.6 billion, the Moroccan pharma sector can be considered only a middling-size…
Company Spotlight / Iberma
Iberma, one of the leading domestic pharma manufacturers in Morocco, has evolved significantly since its founding…
Early Access / The UAE as an Initial Product Launch Platform
The UAE’s distinctive willingness to embrace innovation and the ‘can-do’ spirit of authorities marks the…
People You Should Know in Egyptian Pharma
Egypt has seen a decade of great transformation, from political instability and uncertainty to its current relative…
Rare Diseases in South Africa: Bridging the Gap for Inclusive Healthcare
Kelly du Plessis is CEO & Founder of Rare Diseases South Africa, a registered NPO born out of necessity when…
MEA / UAE to Boost Health Research Capabilities as Part of 50-Year Strategy
The United Arab Emirates’ Cabinet, the de facto executive branch of the federation, recently announced a set of…